JP2025504786A - 肺がんの検出のための組成物および方法 - Google Patents

肺がんの検出のための組成物および方法 Download PDF

Info

Publication number
JP2025504786A
JP2025504786A JP2024540924A JP2024540924A JP2025504786A JP 2025504786 A JP2025504786 A JP 2025504786A JP 2024540924 A JP2024540924 A JP 2024540924A JP 2024540924 A JP2024540924 A JP 2024540924A JP 2025504786 A JP2025504786 A JP 2025504786A
Authority
JP
Japan
Prior art keywords
biomarker
target
polypeptide
detection
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024540924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504786A5 (enExample
Inventor
ジョゼフ チャールズ セドラック，
ローラ テレサ ボートリン，
ダニエル パーカー セイラム，
エミリー スーザン ウィン－ディーン，
ダニエル グーセンライトナー，
アンソニー デイビッド クービロン，
ケリー ビエット，
イブクノルワポ オー． ザブロスキ，
Original Assignee
マーシー バイオアナリティクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マーシー バイオアナリティクス， インコーポレイテッド filed Critical マーシー バイオアナリティクス， インコーポレイテッド
Publication of JP2025504786A publication Critical patent/JP2025504786A/ja
Publication of JP2025504786A5 publication Critical patent/JP2025504786A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024540924A 2022-01-07 2023-01-06 肺がんの検出のための組成物および方法 Pending JP2025504786A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263297684P 2022-01-07 2022-01-07
US63/297,684 2022-01-07
US202263417299P 2022-10-18 2022-10-18
US63/417,299 2022-10-18
PCT/US2023/010358 WO2023133299A1 (en) 2022-01-07 2023-01-06 Compositions and methods for detection of lung cancer

Publications (2)

Publication Number Publication Date
JP2025504786A true JP2025504786A (ja) 2025-02-19
JP2025504786A5 JP2025504786A5 (enExample) 2026-01-15

Family

ID=87074171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024540924A Pending JP2025504786A (ja) 2022-01-07 2023-01-06 肺がんの検出のための組成物および方法

Country Status (5)

Country Link
US (1) US20250223649A1 (enExample)
EP (1) EP4460697A1 (enExample)
JP (1) JP2025504786A (enExample)
CA (1) CA3246896A1 (enExample)
WO (1) WO2023133299A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116904521B (zh) * 2023-09-13 2024-01-26 四川大学华西医院 一种突变型肺腺癌细胞系、构建方法和应用
CN117568353B (zh) * 2023-10-20 2025-09-30 中国科学院基础医学与肿瘤研究所(筹) 一种核酸适体的活体筛选方法及筛选获得的核酸适体
CN120102887B (zh) * 2025-05-10 2025-07-25 浙江格物致知生物科技有限公司 一种检测肺癌的联检产品及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3716986A4 (en) * 2017-12-01 2022-02-09 Cornell University NANOPARTICLES AND VARIOUS EXOSOME SUBSETS FOR CANCER DETECTION AND TREATMENT

Also Published As

Publication number Publication date
CA3246896A1 (en) 2023-07-13
WO2023133299A1 (en) 2023-07-13
US20250223649A1 (en) 2025-07-10
EP4460697A1 (en) 2024-11-13

Similar Documents

Publication Publication Date Title
US20240011993A1 (en) Compositions and methods for detection of lung cancer
US20240368701A1 (en) Compositions and methods for cancer detection
US20250223649A1 (en) Compositions and methods for detection of lung cancer
US20230243834A1 (en) Compositions and methods for detection of ovarian cancer
WO2023004083A2 (en) Compositions and methods for detection of bile duct cancer
US20250297317A1 (en) Compositions and methods for detection of liver cancer
US20250043357A1 (en) Compositions and methods for detection of esophageal cancer
US20240377401A1 (en) Compositions and methods for detection of prostate cancer
US20240369558A1 (en) Compositions and methods for detection of breast cancer
US20240344139A1 (en) Compositions and methods for detection of colorectal cancer
US20240369560A1 (en) Compositions and methods for detection of pancreatic cancer
JP2024543085A (ja) 卵巣がんの検出のための組成物および方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260106